Medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia are frequently associated with changes in sexual function.
While these medications are generally well-tolerated and have both reduced and delayed more invasive surgical options, the ramifications of long-term chronic use are largely unknown. Sexual side effects of these medications are frequently either reported as part of a short-term initial drug study or have inflexible endpoints that are not able to gauge more subtle changes in sexual performance. This review will delineate the currently known effects of these medications on sexual function and will consider mechanisms of dysfunction.
Written by:
Welliver C, Butcher M, Potini Y, McVary KT. Are you the author?
Albany Medical College, Albany, NY, 12208, USA.
Reference: Curr Urol Rep. 2014 Oct;15(10):441.
doi: 10.1007/s11934-014-0441-2
PubMed Abstract
PMID: 25118850
